Skip to main content

Dr. Barry S. Zingman, MD

Infectious Disease (Infectious Disease Physician)

  • Medicare participating

At a glance

Years since graduation
45
In the NPI registry since
2006
Medicare patients seen, 2024
63

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1981Medical school: New York University School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Infectious Disease Physician primary
    NY license 185511

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Infectious Disease per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
63
Services billed
151
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes2727
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2517
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2121
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes1913

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Biktarvy (bictegrav/emtricit/tenofov ala)137
Atorvastatin Calcium
Other prescribers in Bronx, NY
113
Genvoya (elviteg/cob/emtri/tenof alafen)90
Tivicay (dolutegravir sodium)50
Lisinopril
Other prescribers in Bronx, NY
47
Valacyclovir (valacyclovir hcl)
Other prescribers in Bronx, NY
41
Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim)
Other prescribers in Bronx, NY
31
Prezcobix (darunavir/cobicistat)31
Albuterol Sulfate Hfa (albuterol sulfate)
Other prescribers in Bronx, NY
28
Metoprolol Succinate
Other prescribers in Bronx, NY
27

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 1 companies reported 5 payments worth $9,037 in total to this clinician.

By company
Viiv Healthcare Company$9,037
By type
Consulting Fee$8,918
Travel and Lodging$88.76
Food and Beverage$30.56

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Mar 26, 2025Viiv Healthcare Company
Mar 26, 2025
Consulting Fee$5,320
Sep 10, 2025Viiv Healthcare Company
Sep 10, 2025
Consulting Fee
in-kind
$2,600
Mar 26, 2025Viiv Healthcare Company
Mar 26, 2025
Consulting Fee$998
May 21, 2025Viiv Healthcare Company
May 21, 2025
Travel and Lodging
travel to Washington, DC
$88.76

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Industry-funded research

Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $364,460 in research payments for these studies, mostly to the institutions running them.

  • A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With …
    Janssen Research & Development, LLC
  • An interventional efficacy and safety phase 3 doubleblind 2ARM study to investigate orally administered ibuzatrelvir compared with placebo in nonhospitalized symptomatic adult and adolescent participants with COVID19 …
    Pfizer Inc.
  • A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Intravenous Echi…
    Scynexis, Inc.
  • A phase 3 placebocontrolled doubleblinded randomized study to evaluate the efficacy safety and tolerability of a clostridioides difficile vaccine in adults 65 years of age and older
    Pfizer Inc.
  • An interventional efficacy and safety phase 2 randomized doubleblind 2ARM study to investigate a repeat 5DAY course of nirmatrelvirritonavir compared to placeboritonavir in participants at least 12 years of age with r…
    Pfizer Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Infectious Disease clinicians in Bronx

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 11, 2011), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1699850461. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.